Elanco Animal Health Incorporated (ELAN) Stock

Elanco Animal Health Incorporated, headquartered in Greenfield, Indiana, is a leading innovator in animal health, dedicated to the development, manufacturing, and marketing of products for pets and farm animals. Established in 1954, Elanco focuses on providing comprehensive solutions that enhance the health and well-being of animals worldwide.

The company's portfolio includes a wide range of products tailored for both pet and farm animal sectors. For pets, Elanco offers disease prevention solutions such as parasiticides and vaccines under well-known brands like Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco provides therapeutic products addressing pain management, osteoarthritis, ear infections, cardiovascular issues, and dermatological conditions in dogs and cats through brands like Galliprant and Claro.

In the farm animal segment, Elanco delivers vaccines, antibiotics, parasiticides, and nutritional health products for poultry, aquaculture, ruminants, and swine production. These products play a crucial role in ensuring animal health and productivity, supporting beef and dairy farmers, pork producers, poultry operations, and aquaculture facilities globally. Elanco Animal Health remains committed to advancing animal care through ongoing research, innovation, and strategic partnerships in the animal health industry.